Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission-Reference-Cited by-同舟云学术

Bevacizumab Moonshots: An Important Outcome From the Latest Ovarian Cancer Mission

Published:2020-01-10 Issue:2 Volume:38 Page:171-172
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Haines Ian Edwin¹,Gabor Miklos George L.¹

Affiliation:

1. Ian Edwin Haines, MBBS, Monash University at Cabrini Health, Malvern, Victoria, Australia; and George L. Gabor Miklos, PhD, Atomic Oncology, Sydney, New South Wales, Australia

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.01912

Reference8 articles.

1. Addition of Bevacizumab to Chemotherapy for Treatment of Solid Tumors: Similar Results but Different Conclusions

2. Time for a Level Playing Field: Inequalities in Regulatory/Approval Processes—The Example of Bevacizumab in Epithelial Ovarian Cancer

3. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

4. Anti–Vascular Endothelial Growth Factor Therapy in Breast Cancer: Game Over?

5. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A human VEGF magnetic molecularly imprinted polymer for drug-free anti-angiogenesis and photothermal therapy of tumors;Chemical Communications;2023

2. Cost-effectiveness of maintenance therapy after first-line treatment in metastatic colorectal cancer;Journal of Oncology Pharmacy Practice;2021-09-24

3. Pharmacogenomics, Pharmacokinetics and Circulating Proteins As Biomarkers for Bevacizumab Treatment Optimization in Patients with Cancer: A Review;Journal of Personalized Medicine;2020-08-04

4. PARP Inhibitors in Ovarian Cancer;New England Journal of Medicine;2020-04-16

5. Reply to Farolfi et al and Haines et al;Journal of Clinical Oncology;2020-01-10